There has been so much progress in treating cancer in just the past 10 years that it could make your head spin. Researchers have identified new ways to fight cancer -- and new ways to diagnose cancer more effectively, too.
Close to $150 billion will likely be spent on cancer drugs this year. This creates lots of opportunities for investors. But which cancer treatment stocks are the top picks right now? Here's why I think that bluebird bio (NASDAQ: BLUE), Bristol-Myers Squibb (NYSE: BMY), and Intuitive Surgical (NASDAQ: ISRG) especially stand out.
Image source: Getty Images.